Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.89)
# 286
Out of 4,455 analysts
297
Total ratings
50.2%
Success rate
37.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Maintained: Buy | $18 | $3.78 | +376.19% | 8 | Jun 24, 2026 | |
| RLMD Relmada Therapeutics | Reiterated: Buy | $12 | $6.69 | +79.37% | 2 | Jun 23, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | $7 | $0.9688 | +622.54% | 10 | Jun 23, 2026 | |
| ENGN enGene Therapeutics | Maintained: Buy | $6 → $4 | $1.75 | +128.57% | 13 | Jun 16, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $40 | $21.31 | +87.71% | 10 | Jun 15, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $40 | $8.74 | +357.67% | 17 | Jun 2, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $15 | $8.71 | +72.22% | 25 | Jun 2, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $105 | $87.68 | +19.75% | 9 | Jun 2, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $23 | $9.79 | +134.93% | 12 | Jun 2, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $19.96 | +100.40% | 5 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $30.52 | +63.83% | 11 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.64 | +448.78% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.04 | +147.52% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $7.00 | +242.86% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.12 | +555.34% | 16 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $71.96 | +38.97% | 25 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.99 | +81.98% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.01 | +24.92% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $65 | $54.76 | +18.70% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.22 | +208.06% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $0.323 | +1,138.39% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.92 | n/a | 11 | Nov 11, 2024 |
Verastem
Jun 24, 2026
Maintained: Buy
Price Target: $18
Current: $3.78
Upside: +376.19%
Relmada Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $12
Current: $6.69
Upside: +79.37%
TScan Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9688
Upside: +622.54%
enGene Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $6 → $4
Current: $1.75
Upside: +128.57%
Syndax Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: $40
Current: $21.31
Upside: +87.71%
Corbus Pharmaceuticals Holdings
Jun 2, 2026
Reiterated: Buy
Price Target: $40
Current: $8.74
Upside: +357.67%
ImmunityBio
Jun 2, 2026
Reiterated: Buy
Price Target: $15
Current: $8.71
Upside: +72.22%
Monopar Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: $105
Current: $87.68
Upside: +19.75%
Candel Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $23
Current: $9.79
Upside: +134.93%
Immunome
Jun 1, 2026
Reiterated: Buy
Price Target: $40
Current: $19.96
Upside: +100.40%
May 26, 2026
Maintained: Buy
Price Target: $50
Current: $30.52
Upside: +63.83%
May 26, 2026
Maintained: Buy
Price Target: $9
Current: $1.64
Upside: +448.78%
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $4.04
Upside: +147.52%
May 26, 2026
Maintained: Buy
Price Target: $24
Current: $7.00
Upside: +242.86%
May 20, 2026
Reiterated: Buy
Price Target: $27
Current: $4.12
Upside: +555.34%
May 18, 2026
Maintained: Buy
Price Target: $100
Current: $71.96
Upside: +38.97%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $10.99
Upside: +81.98%
May 12, 2026
Reiterated: Buy
Price Target: $20
Current: $16.01
Upside: +24.92%
May 8, 2026
Reiterated: Buy
Price Target: $58 → $65
Current: $54.76
Upside: +18.70%
May 8, 2026
Reiterated: Buy
Price Target: $13
Current: $4.22
Upside: +208.06%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $0.323
Upside: +1,138.39%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $5.92
Upside: n/a